APPLICATION SITE MOVEMENT IMPAIRMENT

APPLICATION SITE MOVEMENT IMPAIRMENT was reported 6 times

These drug classes are most commonly taken by patients reporting APPLICATION SITE MOVEMENT IMPAIRMENT:

# Drug Count
0 Nonsteroidal Anti-inflammatory Drug [EPC] 2
1 Cytolytic Agent [EPC] 1
2 HMG-CoA Reductase Inhibitor [EPC] 1
3 Platelet Aggregation Inhibitor [EPC] 1
4 Programmed Death Ligand-1 Blocker [EPC] 1
5 RANK Ligand Inhibitor [EPC] 1